semaglutide during covid Should I Get Compounded Injections for Weight Loss? Semaglutide Reduces Cardiovascular and COVID

Proactively addressing side effects allows patients to optimize their semaglutide therapy while minimizing any associated risks

The Mumbai Context: Addressing Local Scalp Stressors Living in Mumbai presents specific challenges for scalp health

A landmark 2023 study published in JAMA found that GLP-1 agonist users experienced increased risks of gastrointestinal adverse events (with gastroparesis risk elevated compared to patients using other diabetes medications), while a 2024 case report in PMC documented the strong relationship between semaglutide use and gastroparesis symptoms that resolved only after drug discontinuation

McKenna RW, Washington LT, Aquino DB, Picker LJ, Kroft SH